L. Inker

发表

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

F. Kronenberg, M. Woodward, A. Garg, 2016, JAMA.

Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review

A. Levey, L. Inker, A. Levey, 2017, Clinical pharmacology and therapeutics.

end-organ damage for function of the peripheral vasculature: implications Effects of central arterial aging on the structure and

P. Scheltens, A. Levey, T. Harris, 2015 .

Kidney Disease, Race, and GFR Estimation.

Josef Coresh, N. Powe, J. Coresh, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).

H. Parving, J. Coresh, A. Levey, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hemoconcentration of Creatinine Minimally Contributes to Changes in Creatinine during the Treatment of Decompensated Heart Failure

L. Inker, F. Wilson, S. Coca, 2022, Kidney360.

Effect of Loop Diuretics on the Fractional Excretion of Urea in decompensated Heart Failure.

Jeffrey M. Turner, L. Inker, F. Wilson, 2020, Journal of cardiac failure.

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

M. Landray, M. Pfeffer, J. McMurray, 2017, Kidney international.

Moving toward standardization of urine albumin measurements

J. Coresh, A. Levey, L. Inker, 2017 .

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

J. Coresh, H. Tighiouart, A. Levin, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials.

C. Schmid, J. Coresh, H. Tighiouart, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study.

J. Coresh, A. Levey, T. Greene, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Sathish Kumar Jayapal, Alan D. Lopez, Ravi Prakash Jha, 2020, Journal of the American College of Cardiology.

Validation of a simple equation for glomerular filtration rate measurement based on plasma iohexol disappearance

A. Muñoz, A. Levey, M. Shlipak, 2019, Clinical kidney journal.

Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants

J. Coresh, A. Levey, Xiaoying Gu, 2019, Metabolomics.

Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis

J. Coresh, H. Tighiouart, A. Levey, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.

V. Gudnason, A. Levey, A. Okparavero, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Original Investigation Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis

J. Coresh, H. Tighiouart, A. Levey, 2016 .

Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial.

J. Coresh, A. Levey, L. Appel, 2019, The American journal of clinical nutrition.

Metabolic, cardiovascular, and substance use evaluation of living kidney donor candidates: US practices in 2017

A. Garg, D. Segev, K. Lentine, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.

H. Tighiouart, A. Levey, T. Greene, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

S. Bangalore, A. Chapman, L. Inker, 2021, American Journal of Nephrology.

Evaluation of Surrogate End Points for Progression to ESKD: Necessary and Challenging.

H. Heerspink, L. Inker, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.

J. Coresh, H. Tighiouart, A. Levey, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Original Investigation GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials

J. Coresh, H. Tighiouart, A. Levey, 2014 .

Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.

V. Gudnason, H. Tighiouart, A. Levey, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Biological Variability of Estimated GFR and Albuminuria in CKD.

R. Vasan, P. Kimmel, J. Coresh, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications.

R. Allman, P. Muntner, D. Warnock, 2011, Clinical journal of the American Society of Nephrology : CJASN.

The association of chronic kidney disease complications by albuminuria and glomerular filtration rate: a cross-sectional analysis

H. Tighiouart, M. Sarnak, P. Muntner, 2013, Clinical nephrology.

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study

J. Coresh, M. Grams, L. Inker, 2018, JAMA internal medicine.

Estimated GFR, albuminuria, and complications of chronic kidney disease.

J. Coresh, A. Levey, M. Tonelli, 2011, Journal of the American Society of Nephrology : JASN.

Metabolic complications in elderly adults with CKD.

L. Inker, C. Bowling, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Original Investigation Serum b-Trace Protein and b2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study

R. Vasan, P. Kimmel, J. Coresh, 2016 .

Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland.

V. Gudnason, H. Tighiouart, A. Levey, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Awareness of kidney disease and relationship to end-stage renal disease and mortality.

Keith C. Norris, G. Bakris, M. Shlipak, 2012, The American journal of medicine.

A Prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors.

H. Tighiouart, A. Levey, D. Zanetta, 2022, Kidney international.

Novel Filtration Markers for GFR Estimation

J. Coresh, A. Levey, L. Inker, 2017, EJIFCC.

Estimating glomerular filtration rate using the chronic kidney disease-epidemiology collaboration creatinine equation: better risk predictions.

A. Levey, L. Inker, Kamran Shaffi, 2012, Circulation. Heart failure.

Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease

H. Tighiouart, J. Lewis, T. Greene, 2019, Statistics in medicine.

Strengths and limitations of estimated and measured GFR

J. Coresh, H. Tighiouart, A. Levey, 2019, Nature Reviews Nephrology.

Estimated Glomerular Filtration Rate From a Panel of Filtration Markers-Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate?

J. Coresh, A. Levey, L. Inker, 2018, Advances in chronic kidney disease.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

R. Vasan, P. Kimmel, J. Coresh, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.

G. Beck, J. Coresh, H. Tighiouart, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals.

V. Gudnason, A. Levey, G. Eiriksdottir, 2015, Journal of the American Society of Nephrology : JASN.

Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.

J. Coresh, M. Grams, L. Inker, 2020, JAMA internal medicine.

Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.

J. Coresh, M. Grams, L. Inker, 2019, Mayo Clinic proceedings.

Serum metabolites are associated with all-cause mortality in chronic kidney disease.

J. Coresh, A. Levey, L. Appel, 2018, Kidney international.

Cystatin C and muscle mass in patients with heart failure.

A. Levey, L. Inker, F. Wilson, 2020, Journal of cardiac failure.

Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease.

A. Levey, M. Grams, L. Inker, 2022, The New England journal of medicine.

Associations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFR.

M. Grams, L. Inker, E. Wright, 2019, Clinical journal of the American Society of Nephrology : CJASN.

GFR Estimation Using a Panel of Filtration Markers in Shanghai and Beijing

A. Levey, A. Okparavero, L. Inker, 2020, Kidney Medicine.

Knowing your GFR-when is the number not (exactly) the number?

A. Levey, L. Inker, 2019, Kidney international.

Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients

H. Tighiouart, A. Levey, F. Dekker, 2019, Kidney medicine.

Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia

R. Terkeltaub, V. Perkovic, H. Heerspink, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Estimation of Glomerular Filtration Rate With vs Without Including Patient Race.

H. Tighiouart, A. Levey, L. Inker, 2020, JAMA internal medicine.

Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure.

Jeffrey M. Turner, L. Inker, F. Wilson, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Measurement of glomerular filtration rate

L. Inker, J. Topf, 2019, Nephrology Secrets.

A Roadmap for Estimated Glomerular Filtration Rate: Where Have We Been, Where Are We Now, and Where Do We Need to Go?

L. Inker, 2018, Advances in chronic kidney disease.

Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.

J. Coresh, M. Grams, L. Inker, 2018, Journal of the American College of Cardiology.

Assessment of Glomerular Filtration Rate and End-Stage Kidney Disease Risk in Living Kidney Donor Candidates: A Paradigm for Evaluation, Selection, and Counseling.

K. Lentine, L. Inker, F. Koraishy, 2018, Advances in chronic kidney disease.

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

M. Grams, L. Inker, G. Alexander, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Comparing Newer GFR Estimating Equations Using Creatinine and Cystatin C to the CKD-EPI Equations in Adults.

H. Tighiouart, A. Levey, L. Inker, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial

S. Solomon, M. Pfeffer, A. Levey, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.

J. Coresh, M. Grams, L. Inker, 2014, Diabetes Care.

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

J. Coresh, S. Chadban, O. Djurdjev, 2014, JAMA.

GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

A. Cheung, E. Lewis, J. Coresh, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases

H. Heerspink, M. Grams, L. Inker, 2022, Kidney medicine.

A tripartite complex of suPAR, APOL1 risk variants and alpha(v)beta(3) integrin on podocytes mediates chronic kidney disease

J. Coresh, A. Quyyumi, A. Levey, 2022 .

Strategies for Assessing GFR and Albuminuria in the Living Kidney Donor Evaluation

A. Levey, L. Inker, N. Huang, 2017, Current Transplantation Reports.

Estimated GFR for Living Kidney Donor Evaluation

A. Garg, A. Levey, K. Lentine, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cystatin C for glomerular filtration rate estimation: coming of age.

A. Levey, L. Inker, J. Eckfeldt, 2014, Clinical chemistry.

Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.

A. Levey, L. Inker, M. Froissart, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis.

Tom Greene, A. Levey, T. Greene, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System

J. Coresh, H. Kirchner, K. Matsushita, 2016, Hypertension.

Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2014 CYS Survey.

L. Inker, J. Eckfeldt, A. Karger, 2015, Archives of pathology & laboratory medicine.

Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.

Elizabeth Selvin, John H Eckfeldt, Josef Coresh, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES).

J. Coresh, A. Levey, S. Juraschek, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: A population-based study

M. Grams, L. Inker, E. Selvin, 2022, Lancet Regional Health. Americas.

Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria

D. Fine, T. Nolin, S. Dunning, 2021, Journal of the American Society of Nephrology : JASN.

Effects of Body Size and Composition on Sex Differences in Measured GFR in a US Community-Based Older Cohort (MESA-Kidney).

K. F. Moseley, J. Coresh, H. Tighiouart, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium.

R. Vasan, P. Kimmel, J. Coresh, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.

R. Vasan, P. Kimmel, J. Coresh, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Albuminuria: time to focus on accuracy.

L. Inker, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Imprecise Kidney Function Thresholds in Cancer Clinical Trials and the Potential for Harm

J. Paulus, A. Levey, L. Inker, 2018, JNCI cancer spectrum.

New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

N. Powe, V. Gudnason, A. Rule, 2021, The New England journal of medicine.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

R. Vasan, P. Kimmel, A. Köttgen, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure.

Jeffrey M. Turner, L. Inker, F. Wilson, 2019, The American journal of cardiology.

The effects of freeze-thaw on β-trace protein and β2-microglobulin assays after long-term sample storage.

J. Coresh, S. Juraschek, L. Inker, 2012, Clinical biochemistry.

Kidney Biopsy Teaching Case BK Virus Nephropathy in Heart Transplant Recipients

L. Inker, H. Boucher, D. DeNofrio, 2015 .

BK Virus Nephropathy in Heart Transplant Recipients.

L. Inker, H. Boucher, D. DeNofrio, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Persistent Survival Bene ﬁ t From Remote Ischemic Pre-Conditioning in Patients Undergoing Coronary Artery Bypass Surgery

L. Inker, Sheng-ming Luo, G. Alexander, 2022 .

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Abnormal Serum Potassium Level.

M. Grams, L. Inker, Alex R. Chang, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation

M. Grams, L. Inker, Jung-Im Shin, 2022, Journal of the American Heart Association.

Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.

M. Grams, L. Inker, D. Weiner, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Mixed-eﬀects models for slope-based endpoints in clinical trials of chronic kidney disease

H. Tighiouart, T. Greene, H. Heerspink, 2019 .

GFR Evaluation in Living Kidney Donor Candidates.

A. Levey, L. Inker, 2017, Journal of the American Society of Nephrology : JASN.

Weight changes following antidiabetic mediation use: Real‐world evidence from health system data

M. Grams, L. Inker, E. Selvin, 2022, Obesity science & practice.

In Search of a Better Equation - Performance and Equity in Estimates of Kidney Function.

James A. Diao, N. Powe, H. Tighiouart, 2021, The New England journal of medicine.

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

J. Coresh, A. Levey, L. Appel, 2018, Clinical journal of the American Society of Nephrology : CJASN.

15. Fan F, Yuan Z, Qin X et al. Optimal systolic blood pressure levels for primary prevention of stroke in general hypertensive adults: findings from the CSPPT

J. Coresh, H. Tighiouart, A. Levey, 2018 .

A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient Network.

M. Rocco, N. Tangri, M. Rakibuz-Zaman, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

New GFR-estimating equations for children and young adults in North America and Europe.

A. Levey, L. Inker, 2021, Kidney international.

Estimating Glomerular Filtration Rate in African American Individuals-Reply.

A. Levey, L. Inker, S. Titan, 2020, JAMA internal medicine.

Effects of Bardoxolone Methyl in Alport Syndrome

S. Bangalore, A. Chapman, L. Inker, 2021, Clinical journal of the American Society of Nephrology : CJASN.

National Projections for Clinical Implications of Race-Free Creatinine-Based GFR Estimating Equations

James A. Diao, N. Powe, I. Kohane, 2022, Journal of the American Society of Nephrology : JASN.

Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study

H. Zhang, A. Levey, L. Inker, 2022, Kidney medicine.

Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients.

J. Coresh, A. Levey, L. Inker, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Improving Glomerular Filtration Rate Estimation—Across the Age and Diversity Spectrum

H. Tighiouart, A. Levey, L. Inker, 2020, Annals of Internal Medicine.

Removing Race from GFR Estimates: Balancing Potential Benefits and Unintended Consequences.

L. Inker, C. Wyatt, Anika Lucas, 2021, Kidney international.

The authors reply:

A. Levey, L. Inker, E. Burdmann, 2022, Kidney International.

Performance of Serum β2-Microglobulin– and β-Trace Protein–Based Panel Markers and 2021 Creatinine- and Cystatin-Based GFR Estimating Equations in Pakistan

A. Levey, T. Jafar, L. Inker, 2022, Kidney medicine.

β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery: Non-GFR Determinants and Panel-estimated GFR Performance

J. Coresh, A. Levey, M. Grams, 2021, Kidney Medicine.

Improving glomerular filtration rate estimation.

A. Levey, L. Inker, 2019, Kidney international.

In Reply to 'How Valid Are GFR Estimation Results From the CKD-EPI Databases?'

H. Tighiouart, A. Levey, L. Inker, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Optimal Use of Biomarkers for Chronic Kidney Disease.

L. Inker, J. Vassalotti, J. Delanghe, 2019, Clinical chemistry.

Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

A. Davenport, A. Levin, A. Levey, 2020, Kidney International.

In Reply to 'Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective' and 'Comparing Multiple-Biomarker Panels for Estimating GFR With Estimating Equations Without a Coefficient Distinguishing Black Individuals From Persons of Other Groups'.

A. Levey, L. Inker, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

FP806INITIAL RESULTS FROM A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND IGA NEPHROPATHY

L. Inker, G. Appel, A. Rastogi, 2018 .

Estimated Versus Measured Glomerular Filtration Rate in Men at Risk for Mesoamerican Nephropathy.

L. Inker, Jesse C. Seegmiller, D. Friedman, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR

A. Levey, A. Mocroft, L. Inker, 2020, Kidney international reports.

Serum Cystatin C for Estimation of GFR.

J. Coresh, M. Shlipak, L. Inker, 2022, JAMA.

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project

L. Lund, J. Coresh, J. Carrero, 2017, Journal of the American Heart Association.

Measurement and Estimation of GFR for Use in Clinical Practice: Core Curriculum 2021.

L. Inker, S. Titan, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

GFR as the "Gold Standard": Estimated, Measured, and True.

A. Levey, L. Inker, Andrew S Levey, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease

J. Coresh, A. Quyyumi, A. Levey, 2017, Nature Medicine.

Cerebrovascular Damage Mediates Relations Between Aortic Stiffness and Memory

V. Gudnason, T. Harris, M. van Buchem, 2016, Hypertension.

Bisphosphonate utilization across the spectrum of eGFR

A. Levey, J. Carrero, M. Grams, 2020, Archives of Osteoporosis.

Cystatin C versus creatinine in determining risk based on kidney function.

Josef Coresh, Ronit Katz, Brad C Astor, 2013, The New England journal of medicine.

Estimating glomerular filtration rate from serum creatinine and cystatin C.

Harold I Feldman, Christopher H Schmid, Tom Greene, 2012, The New England journal of medicine.

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Harold I Feldman, Tamara Isakova, Brad C Astor, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

B. Kasiske, L. Inker, R. Mehta, 2011, Kidney international.

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS.

V. Gudnason, J. Coresh, A. Levey, 2019, Clinical chemistry.

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Glenn M. Chertow, Christoph Wanner, David G. Warnock, 2018, American Journal of Nephrology.

ESTIMATION OF GLOMERULAR FILTRATION RATE IN CHRONIC KIDNEY DISEASE BEYOND CREATININE , UREA AND CYSTATIN C Low molecular weight proteins

L. Inker, D. Steubl, 2018 .

Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Adrienne Tin, Lawrence J Appel, Josef Coresh, 2018, Journal of the American Society of Nephrology : JASN.

Metabolomic Alterations Associated with Cause of CKD.

A. Köttgen, J. Coresh, A. Levey, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.

J. Coresh, M. Grams, L. Inker, 2018, Clinical journal of the American Society of Nephrology : CJASN.

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.

N. Powe, M. Mendu, W. S. St. Peter, 2021, Journal of the American Society of Nephrology : JASN.

A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population.

Christian Gieger, Wolfram Gronwald, Gabi Kastenmüller, 2016, Journal of the American Society of Nephrology : JASN.

Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study.

M. Woodward, J. Coresh, A. Levey, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts.

V. Gudnason, H. Tighiouart, A. Levey, 2020, Journal of the American Society of Nephrology : JASN.

"Should the definition of CKD be changed to include age-adapted GFR criteria?": Con: the evaluation and management of CKD, not the definition, should be age-adapted.

J. Coresh, A. Levey, L. Inker, 2020, Kidney international.

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.

M. Landray, F. Kronenberg, M. Woodward, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians

A. Levey, T. Jafar, L. Inker, 2021, Kidney international reports.

Measurement and Estimation of Kidney Function

A. Levey, L. Inker, 2019, Chronic Kidney Disease, Dialysis, and Transplantation.

Con: Should we abandon the use of the MDRD equation in favour of the CKD-EPI equation?

A. Levey, L. Inker, H. Pottel, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes

C. Forsblom, P. Groop, J. Skupień, 2012, Diabetes Care.

Accuracy of a GFR estimating equation over time in people with a wide range of kidney function.

G. Beck, C. Schmid, H. Tighiouart, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients.

A. Rule, A. Levey, K. Uhlig, 2014, American Journal of Kidney Diseases.

Measured and estimated glomerular filtration rate: current status and future directions

J. Coresh, H. Tighiouart, A. Levey, 2019, Nature Reviews Nephrology.

The laboratory diagnostics of chronic kidney diseases Novel filtration markers for GFR estimation

J. Coresh, A. Levey, L. Inker, 2017 .

GFR estimation: from physiology to public health.

J. Coresh, A. Levey, L. Inker, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Performance of Glomerular Filtration Rate Estimating Equations Before and After Bariatric Surgery

J. Coresh, A. Levey, M. Grams, 2020, Kidney medicine.

Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population

Chava L. Ramspek, J. Coresh, A. Levey, 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A New Panel Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population.

G. Beck, V. Gudnason, B. Kasiske, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

A. Davenport, A. Levin, A. Levey, 2020, Kidney international.

Estimation of GFR in South Asians: a study from the general population in Pakistan.

C. Schmid, A. Levey, N. Chaturvedi, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

G. Beck, J. Coresh, H. Tighiouart, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values.

Josef Coresh, J. Coresh, A. Levey, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.

N. Powe, M. Mendu, W. S. St. Peter, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force.

N. Powe, M. Mendu, W. S. St. Peter, 2021, Journal of the American Society of Nephrology : JASN.

Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

J. Coresh, A. Levey, S. Juraschek, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.

B. Astor, J. Coresh, C. Ballantyne, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Filtration markers may have prognostic value independent of glomerular filtration rate.

G. Beck, J. Coresh, N. Tangri, 2012, Journal of the American Society of Nephrology : JASN.

Serum fibroblast growth factor-23 is associated with incident kidney disease.

R. Vasan, P. Kimmel, J. Coresh, 2015, Journal of the American Society of Nephrology : JASN.

Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.

M. Wolf, N. Tangri, T. Greene, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Risk Prediction Models for Patients With Chronic Kidney Disease

Katrin Uhlig, Claudio Rigatto, N. Tangri, 2013, Annals of Internal Medicine.

GFR slope as a surrogate endpoint for CKD progression in clinical trials

L. Inker, Juhi Chaudhari, 2020, Current opinion in nephrology and hypertension.

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.

G. Beck, J. Coresh, H. Tighiouart, 2019, Journal of the American Society of Nephrology : JASN.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

M. Woodward, B. Astor, J. Coresh, 2019, The lancet. Diabetes & endocrinology.

Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials : A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

G. Beck, J. Coresh, H. Tighiouart, 2019 .

Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Anna C. Porter, L. Appel, Jiang He, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

P. Kimmel, J. Coresh, A. Levey, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Past Decline Versus Current eGFR and Subsequent Mortality Risk.

M. Woodward, J. Coresh, C. Fox, 2016, Journal of the American Society of Nephrology : JASN.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

R. Vasan, P. Kimmel, J. Coresh, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.

A. Levey, L. Inker, Cassandra Becker, 2015, JAMA.

Comparison of concurrent complications of CKD by 2 risk categorization systems.

M. Tonelli, B. Hemmelgarn, P. Muntner, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.

B. Kasiske, J. Coresh, M. Grams, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III)

B. Astor, J. Coresh, K. Matsushita, 2012, BMC Nephrology.

Association of sleep-related problems with CKD in the United States, 2005-2008.

Kathryn A. Lee, N. Powe, S. Saydah, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

J. Coresh, K. Matsushita, M. Grams, 2016, Mayo Clinic proceedings.

The kidney evaluation of living kidney donor candidates: US practices in 2017

A. Garg, D. Segev, K. Lentine, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Evaluation of Glomerular Filtration Rate, Albuminuria and Hematuria in Living Donor Candidates

A. Levey, L. Inker, Nitender Goyal, 2021 .

53 – Staging and Management of Chronic Kidney Disease

A. Levey, L. Inker, 2014 .

Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.

J. Coresh, A. Levey, K. Matsushita, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis

L. Magder, H. Tighiouart, C. Coarfa, 2017, Translational research : the journal of laboratory and clinical medicine.

Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.

H. Uno, S. Solomon, M. Pfeffer, 2011, American heart journal.

Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD

G. Remuzzi, C. Wanner, J. Lewis, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Laboratory evaluation of kidney function

L. Inker, W. Miller, 2020 .

Improving Carboplatin Dosing Based on Estimated GFR.

A. Levey, L. Inker, J. Beumer, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis.

J. Coresh, H. Tighiouart, A. Levey, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Level and determinants of kidney function in a South Asian population in Pakistan.

A. Levey, Muhammad Islam, T. Jafar, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Change in albuminuria as a surrogate endpoint in chronic kidney disease - Authors' reply.

J. Coresh, H. Heerspink, R. Gansevoort, 2019, The lancet. Diabetes & endocrinology.

Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

B. Zinman, C. Wanner, H. Heerspink, 2020, Journal of the American Heart Association.

Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States.

J. Coresh, L. Inker, K. Willis, 2013, American heart journal.

Social Determinants of Health and Their Impact on the Black Race Coefficient in Serum Creatinine–Based Estimation of GFR

A. Levey, J. Lewis, T. Greene, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Pro: Estimating GFR using the chronic kidney disease epidemiology collaboration (CKD-EPI) 2009 creatinine equation: the time for change is now.

A. Levey, L. Inker, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization

J. Coresh, M. Grams, L. Inker, 2021, The American Journal of Cardiology.

A Dynamic Predictive Model for Progression of CKD.

D. Kent, N. Tangri, D. Naimark, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.

J. Coresh, H. Tighiouart, A. Levey, 2019, The lancet. Diabetes & endocrinology.

A Novel Creatinine Muscle Index Based on Creatinine Filtration: Associations with Frailty and Mortality

J. Coresh, A. Levey, M. Grams, 2023, Journal of the American Society of Nephrology : JASN.

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data.

M. Woodward, B. Astor, J. Coresh, 2019, Journal of the American Society of Nephrology : JASN.

Within-person variability in kidney measures.

J. Coresh, A. Levey, S. Juraschek, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cystatin C as a marker of glomerular filtration rate: prospects and limitations

A. Okparavero, L. Inker, 2011, Current opinion in nephrology and hypertension.

Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes

H. Tighiouart, G. Remuzzi, M. Sarnak, 2023, Journal of the American Society of Nephrology : JASN.

Mediation analysis of aortic stiffness and renal microvascular function.

V. Gudnason, A. Levey, T. Harris, 2015, Journal of the American Society of Nephrology : JASN.

Use of Glomerular Filtration Rate Estimating Equations for Drug Dosing in HIV-Positive Patients

H. Tighiouart, A. Okparavero, L. Inker, 2013, Antiviral therapy.

Long-Term Longitudinal Stability of Kidney Filtration Marker Measurements: Implications for Epidemiological Studies and Clinical Care.

J. Coresh, A. Levey, F. van Lente, 2020, Clinical chemistry.

Performance of Creatinine and Cystatin C GFR Estimating Equations in an HIV-Positive Population on Antiretrovirals

C. Schmid, H. Tighiouart, A. Levey, 2012, Journal of acquired immune deficiency syndromes.

A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease.

J. Coresh, A. Levey, E. Guallar, 2021, Kidney international.

The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease.

Lawrence J Appel, Josef Coresh, J. Coresh, 2019, The Journal of nutrition.

Segmental kidney volumes measured by dynamic contrast-enhanced magnetic resonance imaging and their association with CKD in older people.

Vilmundur Gudnason, Tamara B Harris, Lenore J Launer, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.

A. Köttgen, B. Astor, J. Coresh, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.

C. Schmid, A. Levey, T. Greene, 2016, American Journal of Kidney Diseases.

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force.

N. Powe, M. Mendu, W. S. St. Peter, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Performance of GFR Slope as a Surrogate Endpoint for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.

J. Coresh, H. Tighiouart, A. Levey, 2019, Journal of the American Society of Nephrology : JASN.

Chronic Kidney Disease in Older People.

Josef Coresh, J. Coresh, A. Levey, 2015, JAMA.

Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort.

V. Gudnason, H. Tighiouart, A. Levey, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development

T. Nolin, L. Inker, G. Alexander, 2023, Clinical journal of the American Society of Nephrology : CJASN.

3 – Assessment of Glomerular Filtration Rate in Acute and Chronic Settings

A. Levey, L. Inker, 2014 .

FC052: Atrasentan for the Treatment of IGA Nephropathy: Interim Results from the Affinity Study

L. Inker, Sang-ho Lee, M. Wong, 2022, Nephrology, Dialysis and Transplantation.

Performance of Indexed and Nonindexed Estimated GFR.

H. Tighiouart, A. Levey, M. Shlipak, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts

J. Coresh, N. Tangri, D. Naimark, 2023, Journal of the American Society of Nephrology : JASN.

Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes Mellitus.

J. Coresh, N. Tangri, D. Naimark, 2022, Diabetes care.

The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.

J. Coresh, S. Dunning, M. Grams, 2020, Journal of the American Society of Nephrology : JASN.

Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care

J. Carrero, B. Wettermark, M. Grams, 2021, Clinical kidney journal.

Aortic stiffness and change in glomerular filtration rate and albuminuria in older people

V. Gudnason, A. Levey, T. Harris, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Estimating residual kidney function in dialysis patients without urine collection.

J. Coresh, A. Levey, F. Dekker, 2016, Kidney international.

National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories.

A. Levey, J. Lieske, G. Horowitz, 2021, Clinical chemistry.

Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey.

V. Gudnason, A. Levey, G. Eiriksdottir, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

M. Woodward, H. Tighiouart, C. Wanner, 2021, Journal of the American Society of Nephrology : JASN.

Improved Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists' 2019 CYS Survey.

L. Inker, J. Eckfeldt, A. Karger, 2022, Archives of pathology & laboratory medicine.

Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes

H. Tighiouart, T. Copeland, M. Sarnak, 2023, American Journal of Kidney Diseases.

Biomarkers of Vitamin D Status and Risk of ESRD.

R. Vasan, P. Kimmel, J. Coresh, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials.

M. Vaduganathan, T. Greene, V. Perkovic, 2023, Kidney international.

Design and Population of the VALOR-CKD Study: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating the Efficacy and Safety of Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis.

N. Tangri, V. Perkovic, D. Wheeler, 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis

M. Grams, L. Inker, Jung-Im Shin, 2019, Mayo Clinic proceedings.

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019

F. Hu, V. Feigin, T. Vos, 2020 .

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

M. Landray, J. Chan, K. Mahaffey, 2023, Nature Medicine.

Discordances Between Creatinine and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.

A. Levey, M. Grams, L. Inker, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Discordance in GFR Estimating Equations and Dosing Guidance by Body Mass Index and Age.

T. Nolin, M. Grams, L. Inker, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Prospective Cross-Sectional Study on the Performance of the 2021 CKD-EPI Equations Without Race in a Multiracial Population of Adults With Solid Tumors in Brazil.

H. Tighiouart, A. Levey, D. Zanetta, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease

A. Quyyumi, A. Levey, C. Winkler, 2017, Nature Medicine.

In reply to 'Creatinine-based GFR estimating equations in kidney transplant recipients' and 'Assessing kidney function in transplant recipients: time to work together and address the most relevant questions'.

A. Levey, L. Inker, Kamran Shaffi, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients.

A. Rule, A. Levey, K. Uhlig, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review

A. Levey, L. Inker, P. Palevsky, 2023, Kidney medicine.

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

F. Kronenberg, M. Woodward, A. Garg, 2016, JAMA.

University of Groningen Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes CKD Prognosis Consortium; Grams,

N. Tangri, D. Naimark, A. Levin, 2022 .

Accuracy of a GFR estimating equation over time in people with a wide range of kidney function.

G. Beck, C. Schmid, H. Tighiouart, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum fibroblast growth factor-23 is associated with incident kidney disease.

R. Vasan, P. Kimmel, A. Levey, 2015, Journal of the American Society of Nephrology : JASN.

Do We Need a New Creatinine-Based Estimated GFR Equation For Kidney Transplant Recipients?

L. Inker, A. Chami, Andrew S. Levey, 2023, American Journal of Kidney Diseases.

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

M. Landray, M. Pfeffer, J. McMurray, 2017, Kidney international.

Managing Chronic Kidney Disease in Older People--Reply.

A. Levey, L. Inker, J. Coresh, 2016, JAMA.

Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.

V. Gudnason, H. Tighiouart, A. Levey, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Baclofen and the risk of fall and fracture in older adults: A real‐world cohort study

L. Inker, Jung-Im Shin, Y. J. Hwang, 2023, Journal of the American Geriatrics Society.

Performance of Creatinine and Cystatin C GFR Estimating Equations in an HIV-Positive Population on Antiretrovirals

C. Schmid, H. Tighiouart, A. Levey, 2012, Journal of acquired immune deficiency syndromes.

Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.

C. Schmid, A. Levey, T. Greene, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR.

M. Landray, F. Kronenberg, B. Brenner, 2018 .

Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease

M. Grams, L. Inker, Jung-Im Shin, 2023, Circulation.

Baclofen and the Risk of Encephalopathy: A Real-World, Active-Comparator Cohort Study.

D. Brotman, M. Grams, L. Inker, 2023, Mayo Clinic proceedings.

Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.

A. Köttgen, B. Astor, A. Levey, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations

A. Levey, J. Carrero, F. Dekker, 2023, Journal of the American Society of Nephrology : JASN.

Consistency of metabolite associations with measured glomerular filtration rate in children and adults

A. Levey, Taibo Li, M. Grams, 2024, Clinical kidney journal.

Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR

V. Gudnason, A. Levey, M. Shlipak, 2023, Kidney medicine.

Chronic Kidney Disease Progression in Heart Failure: What We Know, Don't Know, and Where to Next?

L. Inker, B. Neuen, Hiddo J. L. Heerspink, 2024, JACC. Heart failure.

Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials

H. Heerspink, L. Inker, Willem Collier, 2024, BMC medical research methodology.

Long‐Term Changes in Estimated Glomerular Filtration Rate in Left Ventricular Assist Device Recipients: A Longitudinal Joint Model Analysis

G. Gulati, H. Tighiouart, L. Inker, 2023, Journal of the American Heart Association.

Estimated GFR in the Korean and US Asian Populations Using the 2021 Creatinine-Based GFR Estimating Equation Without Race

L. Inker, Morgan E. Grams, Jimin Hwang, 2024, Kidney Medicine.

Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C

A. Levey, L. Inker, Y. Sang, 2024, Annals of Internal Medicine.